LexDanaLexDanabeta
Inventor

Zef KONST

Inventor
US

Overview

3→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07BGeneral methods of organic chemistry18%
PatentTitleYear
12,582,722Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway202612,338,220Antiviral pyrazolopiridinone compounds202511,667,613Antiviral pyrazolopyridinone compounds2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2025Patents assigned to GILEAD SCIENCES INC (2)· patent assignee history
2023–2025Patents assigned to NOVARTIS AG (2)· patent assignee history
2023–2026Based in US· patent location history
2026Patents assigned to NURIX THERAPEUTICS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GILEAD SCIENCES INC22023–2025
NOVARTIS AG22023–2025
NURIX THERAPEUTICS INC12026
Locations
LocationPatentsSpan
US32023–2026